In our Scottsdale clinic, we often combine peptide therapy with: Hormone testing and optimization Food sensitivity analysis IV therapy for metabolism and detox support Personalized nutrition planning Ongoing coaching and naturopathic oversight This integrative approach maximizes the results of AOD 9604 and helps patients reach their goals safely and sustainably
Molecular Characteristics Compound Name: hGH Fragment 176191 CAS Number: 66004-57-7 Peptide Length: 16 amino acids Molecular Formula: C78H123N23O23 Molecular Weight: ~1817 g/mol Form: Lyophilized peptide powder Purity: 99% HPLC verified Stability Profile and Storage Recommendations Store lyophilized peptide at 20C Protect from moisture and direct light exposure Avoid repeated freezethaw cycles Reconstituted solutions should be refrigerated Handle using aseptic laboratory techniques Solubility and Reconstitution Options Sterile bacteriostatic water Sterile saline solutions Buffered aqueous laboratory solutions Biochemical assay buffers Laboratory-grade solvent systems Technical Specifications product Name hGH Fragment 176191 6mg brand BioPeptides cas 66004-57-7 purity 99% (HPLC verified) unit Size 6mg vial form Lyophilized powder synthesis Solid-Phase Peptide Synthesis (SPPS) analytical HPLC and Mass Spectrometry molecular Structure Synthetic growth hormone fragment stability Stable when stored at 20C Analytical Validation and Quality Assurance High-performance liquid chromatography purity verification Mass spectrometry molecular weight confirmation Peptide structural integrity validation Batch-to-batch analytical consistency testing Peptide stability verification Regulatory and Compliance Statement hGH Fragment 176191 supplied by BioPeptides is intended strictly for laboratory and scientific research use only
Unlike earlier compounds that affected multiple methyltransferases, 5-amino-1MQ demonstrates remarkable specificity for NNMT without inhibiting related SAM-dependent enzymes or components of the NAD+ salvage pathway
Pharmaceutical pipeline: there are no Phase 1 through Phase 3 trials of 5-Amino-1MQ itself registered on ClinicalTrials.gov as of June 2026
Subsequent development as an obesity drug was discontinued due to the small effect size, though research continues on its potential role in cartilage repair and localized metabolic applications
Lipo MICC + B12 is a compounded lipotropic injection containing four metabolic support compounds Methionine, Inositol, Choline, and Carnitine combined with Methylcobalamin (the active form of Vitamin B12)
